 |
Talking About Tumors with Ryann and Ryan - A medical oncology podcastAuthor: Talking About Tumors
Designed for residents and fellows to provide an overview of the clinical practice and evidence behind management of each individual tumor site. Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, cancer Language: en-us Genres: Education, Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
01_09a Daroxonrasib: A KRAS(on) inhibitor (mini-discussion)
Episode 3
Sunday, 7 June, 2026
1. RAS as an oncogene2. The undruggable RAS3. KRAS G12C as a specific exception4. Daroxonrasib as a pan RAS(On) inhibitor CitationsAs always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice. DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.Uptodate.com Waltham, MA: Wolters Kluwer. 1. Wang-Gillam A , et al. Eur J Cancer. 2019;108:78-87. doi:10.1016/j.ejca.2018.12.0072. O’Reilly EM et al. N Engl J Med. Published online May 31, 2026. doi:10.1056/NEJMOA26055553. Cregg J et al. J Med Chem. 2025;68(6):6041-6063. doi:10.1021/ACS.JMEDCHEM.4C02313/4. Fakih MG et al. Engl J Med. 2023;389(23):2125-2139. doi:10.1056/NEJMOA23087955. de Langen AJ, et al. The Lancet. 2023;401(10378):733-746. doi:10.1016/S0140-6736(23)00221-06. Cox AD et al. Nat Rev Drug Discovery 2014 13:11. 2014;13(11):828-851. doi:10.1038/nrd4389 DisclosuresTalking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.
